SWAN Capital »

Gt Biopharma shares owned by SWAN Capital

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by SWAN Capital from 13F filings

Historical chart of SWAN Capital investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by SWAN Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by SWAN Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $785 1.0k 0.79

More positions owned by SWAN Capital

Vanguard Whitehall Fds Intl High Etf (VYMI)
Vanguard Scottsdale Fds Lg-term Cor Bd (VCLT)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Ishares Tr Pfd And Incm Sec (PFF)
Vanguard World Inf Tech Etf (VGT)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard World Energy Etf (VDE)
Vanguard World Utilities Etf (VPU)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Vanguard Index Fds Mcap Gr Idxvip (VOT)

View all positions for SWAN Capital

Top funds holding Gt Biopharma

Scientech Research
SeaCrest Wealth Management
Citadel Advisors
Jane Street
Integrated Wealth Concepts
Geode Capital Management
Coston, McIsaac & Partners
Caitlin John
Wells Fargo & Company
HPM Partners
Am Investment Strategies
Verdence Capital Advisors
Two Sigma Securities
Prospera Financial Services
Hrt Financial

View all funds holding Gt Biopharma